✦ LIBER ✦

Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies

✍ Scribed by Sheffer, Albert L.; Campion, Marilyn; Levy, Robyn J.; Li, H. Henry; Horn, Patrick T.; Pullman, William E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous Ecallantide for the Treatme

✍ Albert Sheffer; Patrick Horn; William Pullman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Results of a 2-Stage, Phase 3 Pivotal Tr

✍ LEVY, R; MCNEIL, D; LI, H; HSU, F; HORN, P; ROBERTS, J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Results From FAST-3: A Phase III Randomi

✍ Lumry, W.R.; Li, H.H.; Levy, R.J.; Potter, P.C.; Farkas, H.; Reshef, A.; Moldova 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A randomised, placebo-controlled, double

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB